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SUMMARY
Melarsomine hydrochloride can cure Trypanosoma evansi infection in camels at a dose of 0·25mg/kg, but at that dose
relapses occur in cattle. In our study, the eﬃcacy of an intramuscular injection of melarsomine hydrochloride at 0·5 mg/kg
was assessed in 3 normal and 3 splenectomized dairy cattle experimentally infected with a stock of T. evansi from Thailand.
The animals were monitored for 5 months by haematocrit centrifugation, blood- or cerebrospinal ﬂuid-mouse inoculation,
polymerase chain reaction, the card agglutination test (CATT) for T. evansi, and the enzyme-linked immunosorbent
assay‑T. evansi. Parasitological and DNA tests became and remained negative just after treatment. By the end of the
experiment, CATTwas negative and ELISA scores were below or very close to the cut-oﬀ value. One of the splenectomized
cattle died from anaplasmosis during the experiment, but tested negative for surra. It was concluded that the parasites had
been cleared from the cattle, and melarsomine hydrochloride at 0·5 mg/kg can be recommended for treatment against
T. evansi infection in dairy cattle in Thailand. Further work is necessary to validate the eﬃcacy of the treatment in the event
of conﬁrmed CSF-infection.
Key words: Trypanosoma evansi, melarsomine hydrochloride, cattle, splenectomized cattle, Thailand, parasitological cure,
drug eﬃcacy.
INTRODUCTION
Trypanosoma evansi is mainly a parasite of camelids,
equids and carnivores, but it is also pathogenic in
a number of wild and other domestic host species
(Gill, 1977). In Africa andLatinAmerica, cattle seem
to have low susceptibility to T. evansi, but in Asia
clinical signs with a signiﬁcant impact are regularly
described in buﬀaloes and cattle (Luckins, 1988;
Reid, 2002; Dargantes et al. 2009).
During the course of T. evansi infection in cattle,
parasitaemia is frequently low, but it can occasionally
be as high as in other trypanosome infections (Gill,
1977; Chobjit et al. 2006). With recurrent trypano-
cide treatments in the ﬁeld, especially at subcurative
doses, the immune control of parasitaemia increases,
which lowers parasitaemia to undetectable levels
(Desquesnes, 2004); under such conditions, it is
sometimes diﬃcult to determine with certainty
whether treated animals have actually been cured
(complete elimination of the parasite), or whether
they have become healthy carriers and could con-
stitute a potential reservoir. Testing a trypanocide
in splenectomized animals, hence with reduced
natural resistance, would demonstrate the eﬃcacy of
the chemical itself, despite the artiﬁcial immunosup-
pression.
T. evansi infection can be cured using trypanocides
such as isometamidium chloride and diminazene
aceturate, but products such as quinapyramine
and melarsomine hydrochloride are more suitable.
Melarsomine hydrochloride (Mel Cy) (Cymelarsan®)
is the only trypanocide speciﬁcally recommended
for controlling T. evansi in camels, at a dose of
0·25 mg/kg by deep intramuscular injection. How-
ever, the manufacturer (Merial®) has never deﬁned
a melarsomine hydrochloride dose for other host
species. Studies conducted in various situations have
shown infection relapses when using 0·25mg/kg in
cattle and buﬀaloes; higher doses were then suggested
for theseBovinae (Lun et al. 1991; Payne et al. 1994a;
Dia and Desquesnes, 2007).
In Thailand, although isometamidium chloride
has occasionally been used and quinapyramine was
* Corresponding author: Faculty of Veterinary Medicine,
Kasetsart University, Chatuchak, Bangkok, 10900
Thailand. Tel: +66 (0) 8 49 40 72 68. Fax: +66 (0) 29 42
86 84. E-mail: fvetspj@yahoo.com
1134
Parasitology (2011), 138, 1134–1142. © Cambridge University Press 2011
doi:10.1017/S0031182011000771
http://dx.doi.org/10.1017/S0031182011000771
Downloaded from http:/www.cambridge.org/core. Open University Libraryy, on 22 Dec 2016 at 23:11:35, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms.
used in the past (Indrakamhang, 1998), diminazene
aceturate is the only trypanocide regularly available,
which is used extensively to control surra in horses,
buﬀaloes, cattle, pigs, deer, elephants and dogs
(Tuntasuvan and Luckins, 1998). After more than
40 years of regular use, treatment failures, most
probably due to chemoresistance to diminazene
aceturate, are regularly reported from the ﬁeld
(Tuntasuvan et al. 2003a,b; Hin-On et al. 2004). In
some cases, relapses have been observed in cattle from
Chiang Mai province, despite treatments at a dose of
10mg/kg (Rodtian P, unpublished observation).
In our study, we assessed the eﬃcacy of the intra-
muscular injection of 0·5 mg/kg of melarsomine
hydrochloride as a parasitological cure in normal
and splenectomized cattle experimentally infected
with a Thai strain of T. evansi.
MATERIALS AND METHODS
Animals
Six 10-month-old dairy cattle, 82·75% Holstein
Friesian-type breed (crossed with a local breed),
from a dairy farm free of trypanosomosis, and testing
negative in parasitological (Haematocrit Centrifuge
Technique, HCT) (Woo, 1970) and serological tests
(card agglutination test for trypanosomes (CATT/
T. evansi) and ELISA-T. evansi), were randomly
selected from a batch of 30 animals. They were kept
in a ﬂy-proof stable in Pathumthani province.
To demonstrate the eﬃcacy of the treatment itself,
and to ensure that the parasites would not be
inhibited or killed solely by a combination of drug
eﬀects and host immune responses, half of the
experimental animals were immunosuppressed by
splenectomy. Thus, 45 days prior to the experiment,
3 of the 6 cattle were randomly selected and
splenectomized. For this minor surgery (less than
30min) an intravenous injection of 2ml of 2%
xylazine solution (Rompun®) was given, as rec-
ommended by the manufacturer (Bayer®).
Parasites
A Thai strain of T. evansi previously isolated from
highly parasitaemic cattle in Bangkok, and charac-
terized by PCR with speciﬁc primers (Masiga et al.
1992; Panyim et al. 1993), passed once through a
mouse and cryopreserved in liquid nitrogen, was
recovered by intraperitoneal injection of 3 mice. At
the peak of parasitaemia (days 3–5), the mice were
anaesthetized with a combination of zolazepam and
tiletamine (Zoletil®) and bled to death; blood was
collected in a citrated tube (Fushino® Na citrate,
3·2%) and diluted 1:2 in phosphate saline glucose
(PSG). Parasites were counted as previously de-
scribed (Desquesnes and Tresse, 1996). After
optimized dilution in PSG, approximately 105
trypanosomes were injected into the jugular vein of
each of the cattle on Day 0 of the experiment.
Melarsomine hydrochloride treatment
On Day 50, the cattle were weighed and were given
a deep intramuscular injection of 0·5 mg/kg of
melarsomine hydrochloride (Cymelarsan®, batch
D01601A, Merial).
Cattle sampling
Ten ml of blood were regularly collected from the
jugular vein of the animals at intervals of 2–7 days
from Day 0 to Day 151; 2·5 ml was kept in EDTA
tubes for HCT, mice inoculation and preparation of
the buﬀy-coat for PCR. The rest was left at room
temperature for 24 h to allow clotting. Sera were
collected and kept at −20 °C until further use. On
Day 99, 2 ml of cerebrospinal ﬂuid (CSF) were
collected by puncture at the sacrococcygeal vertebral
junction for the CSF mouse inoculation test
(CSFMIT).
In the event of death during the experiment, an
autopsy was carried out to collect blood, aqueous
humour of the eyes, joint ﬂuid from the scapulo-
humeral, hip and/or femoro‑tibial joints, CSF from
the occipital joint, and brain samples (cerebrum and
cerebellum). The blood was used for HCT and
BMIT (see below). The CSF was used for the mouse
inoculation test (CSFMIT). The CSF, joint ﬂuid
and aqueous humour of the eyes were used for ﬂuid
pellet microscopic observation and PCR (see below).
Parasitological examinations
Directmicroscopic examination was conducted in the
mice by observing 10 μl of blood collected from the
tip of the tail and placed between a slide and cover-
slip (22×22mm), under dark ground conditions at
×400 magniﬁcation; the number of parasites was
estimated as previously described (Desquesnes and
Tresse, 1996). The parasitaemia 95% conﬁdence
interval (CI) was calculated as CI=mean+/−1·96
S/
√
n, and the mean parasitaemias were compared
using the Student’s t-test (Ancelle, 2002). The
haematocrit centrifuge technique (HCT) was used
on the cattle after centrifugation of 70 μl of blood in a
capillary tube, at 10000 g for 5 min, and by direct
microscopic observation of the buﬀy coat (Woo,
1970).
Fluid-pellet microscopic examination. Duplicate
samples of 0·5 ml of cattle aqueous humour of the
eye, or joint ﬂuid diluted 1:2 in PSG, or CSF were
centrifuged at 10000 g for 10min; the supernatant
was discarded. One of the pellets was preserved at
−20 °C for PCR, and the other was re‑suspended in
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the remaining supernatant and deposited between the
slide and cover-slip for direct microscopic examin-
ation under dark ground conditions.
Blood-mouse inoculation tests (BMIT) or cerebro-
spinal ﬂuid-mouse inoculation tests (CSFMIT) were
carried out by intraperitoneal injection of 0·25ml of
cattle blood or CSF, respectively, into 1 mouse each.
The mice were monitored 3 times a week for 3 weeks
by direct microscopic examination of blood from the
tail. The animals were considered negative when
parasites were still not found 3 weeks after inocu-
lation.
PCR diagnosis
A sample of 100 μl of buﬀy coat collected from the
centrifugation of 1ml of blood, or pellets from the
centrifugation of 0·5 ml of ﬂuids (CSF, joint ﬂuid,
aqueous humour of the eyes) underwent DNA
puriﬁcation using the phenol/chloroform method
(Sambrook and Russell, 2001). PCR was carried out
in 10 μl volumes of master mix with 1 μl of sample,
using TBR primers according to a technique already
described (Masiga et al. 1992). PCR products,
including positive and negative controls, were elec-
trophoresed for 1 h at 120 V in 2% agarose gels,
together with Generuler® 100-bp DNA ladder plus
(Fermentas, Invitrogen Corporation, Van Allen
Way, Carlsbad, CA, USA), stained with ethidium
bromide and visualized under UV light.
Serological examination
(1) The card agglutination test for trypanosomes
(CATT/T. evansi) (antigen lot 10A1B2) was carried
out on sera diluted 1:4 as described by the manu-
facturer (Prince Leopold Institute of Tropical
Medicine, Belgium) (Bajyana Songa and Hamers,
1988). (2) The ELISA procedure has been described
previously (Desquesnes et al. 2009). Brieﬂy,
Microtest 96-well Polysorp Nunc® immunoplates
(Nunc, Roskilde, Denmark) were coated with 100 μl/
well of T. evansi soluble antigen at 5 μg/ml protein
concentration in carbonate buﬀer (pH 9·6) overnight
at 4 °C. The plates were blocked with 150 μl/well of
blocking buﬀer: phosphate-buﬀered saline (PBS)
with 0·1% Tween 20® (Sigma-Aldrich) and 7%
Wako skim milk powder (ref: 190-12865, Wako
Pure Chemical Industries Ltd, Osaka, Japan),
under permanent stirring (150 rpm) for 45min at
37 °C. After discarding the blocking buﬀer, sera
diluted 1:100 in blocking buﬀer were transferred in
duplicate to the ELISA plates. After 30min of
incubation in a shaker-incubator (37 °C, 150 rpm),
the plates were washed 7 times with washing buﬀer
(PBS-0·1% Tween 20®). Then, 100 μl of peroxidase-
conjugated anti-bovine IgG (A5295, Sigma-
Aldrich), diluted 1:10000 in blocking buﬀer, were
added and the plates incubated for 30min (37 °C,
150 rpm). After discarding the sera, the plates were
washed 7 times and added to 100 μl of the substrate/
chromogen complex 3,3′,5,5′-tetramethylbenzidine
(TMB) (Sureblue® TMB Microwell Peroxidase
Substrate, Gaithersburg, Maryland, USA). The
plates were incubated in a dark room for 30min.
Optical density (OD) was measured at 630 nm in an
ELISA reader (Dynex Technologies®, Chantilly,
VA, USA). ELISA T. evansi results were expressed
as a relative percentage of positivity (RPP) versus
3 negative and 3 positive controls, as previously
described (Desquesnes et al. 2007). Positive results
were conﬁrmed when the RPP was above 20%.
Chronological feature of the protocol
The 6 cattle were sampled at Day −50 and Day 0,
prior to infection. Three cattle were splenectomized
at Day −45. All cattle were sampled regularly at 2 to
7-day intervals between Day 0 and Day 151. The 6
cattle were experimentally infected at Day 0. At Day
50, the 6 cattle were weighed and received 0·5 mg/kg
of melarsomine hydrochloride in a deep intramus-
cular injection. On Day 99, blood and CSF were
collected from the 6 cattle for BMIT and CSFMIT.
The experiment was terminated 100 days after
treatment (Day 151).
RESULTS
Initial parasitological (HCT), molecular (PCR) and
serological tests (CATT and ELISA) of the
6 animals, carried out at Day −50 and Day 0 were
all negative; RPP values in ELISA were all less than
10%. Three randomly selected dairy cattle were
splenectomized and named SC17, SC16 and SC9.
The other 3 were named C22, C21 and C32. SC17
developed acute anaplasmosis on Day −40 when
Anaplasma marginale were observed on Giemsa-
stained blood smears (8·9% infected blood cells),
probably as a secondary eﬀect of splenectomy.
The animal received intramuscular treatment with
10mg/kg of oxytetracycline. A. marginale disap-
peared from the stained blood smears after Day
−37. It was therefore concluded that the animal was
cured of anaplasmosis.
All the animals were inoculated via the jugular vein
with 105 T. evansi on Day 0, and tested positive by
microscopic observation of the buﬀy coat or direct
blood observation and PCR from Day 4 post-
infection and remained regularly positive until they
were treated on D50 (Table 1). Parasitaemia was low,
and did not exceed 135000 parasites/ml, but it was
almost always detectable by HCT, except for 6 out
of 54 samples collected between Day 4 and Day 50.
Parasitaemia ﬂuctuated greatly from one animal to
another and from day to day, and it was higher in the
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splenectomized animals (conﬁdence interval, CI=14
532±7023 parasites/ml) than in the normal cattle
(CI=8919±10011 parasites/ml), but the diﬀerence
was not statistically signiﬁcant (t=0·90<1·96; de-
grees of freedom=52). Over that period, only 1
sample out of 54 (animal C22 onDay 15) was negative
by PCR (Table 1).
After treatment, all the animals were conﬁrmed
negative by HCT and PCR up to the end of the
experiment. BMIT and CSFMIT carried out on
samples collected from all the cattle on D99 were all
negative.
The CATT/T. evansi results were all negative
prior to infection. After infection, CATT results
remained negative in 2 animals (C21 and C22); they
were doubtful in some instances in 2 other animals
(C32 and SC16), and they were occasionally positive
(5 occurrences) in the last 2 animals (SC17 and SC9),
between Day 6 and Day 42. The results are presented
in Table 2. After Day 56, all CATT values were
negative in all the animals for 3 months, up to the end
of the experiment. Due to the poor performance of
the CATT, a new batch of CATT T. evansi was
ordered (antigen lot 10A1B2; expiry inOctober 2011)
and CATT tests were performed again with the same
samples. The results obtained were very similar and
showed a total of 6 positive results and 7 doubtful
results.
The results obtained by ELISA are indicated in
Fig. 1 for the normal cattle and Fig. 2 for the splen-
ectomized cattle. The animals became positive at
26 (±6) days post-infection in the normal cattle and
20 (±7) days post-infection in the splenectomized
cattle, with an average of 21 (± 6) days post-infection
(no signiﬁcant diﬀerences). All samples remained
positive throughout the infection, with the exception
of 3 samples from 2 splenectomized cattle (see Fig. 2,
before Day 50). Immune responses in the normal
cattle were clearly higher (RPP>50%) than in the
splenectomized animals, of which only 1 displayed
RPP over 50%, between Day 22 and Day 42. After
treatment (Day 50), RPP declined gradually.
Samples were classiﬁed as negative by ELISA at 45
(±25) days post-treatment (p.t.) in the normal cattle,
and at 25 (±15) days p.t. in the splenectomized cattle.
From the 45th day p.t., all the animals were negative
except one of the normal cattle (C32), which
remained positive up to Day 131 (80 days p.t.) and
was then irregularly negative but close to the positive
threshold when the experiment ended. At the end of
the experiment, the RPP of SC32was regularly below
25% but not yet regularly negative.
Only 1 of the splenectomized cattle (SC17) had a
high RPP, and the others exhibited a low response
in ELISA, being irregularly and weakly positive
(Fig. 2). SC17 developed an anaplasmosis relapse on
Day 77 and was treated with 10mg/kg of oxytetracy-
cline on Day 78. A. marginale disappeared from the
blood observation after Day 81, but the animal never
recovered from this infection; in the absence of fever
or other obvious infectious signs, SC17 showed
serious loss of appetite and weight, and ﬁnally died
Table 1. Results of the HCT and PCR (TBR) in 3 normal and 3 splenectomized cattle experimentally
infected by T. evansi (D0) and treated with melarsomine hydrochloride (D50)
Animal numbers C22 C21 C32 SC17 SC16 SC9
Day post-infection HCT PCR HCT PCR HCT PCR HCT PCR HCT PCR HCT PCR
0 0 0 0 0 0 0 0 0 0 0 0 0
4 135000 1 1125 1 1125 1 1125 1 3000 1 3000 1
6 27000 1 1125 1 1125 1 25000 1 0 1 0 1
15 0 0 3000 1 4500 1 25000 1 27000 1 81000 1
21 0 1 1200 1 2250 1 7500 1 27000 1 54000 1
27 300 1 450 1 0 1 7500 1 9000 1 25000 1
29 500 1 1500 1 600 1 3000 1 5000 1 1500 1
35 27000 1 1500 1 1500 1 7500 1 27000 1 20000 1
42 27000 1 450 1 750 1 750 1 8000 1 1500 1
50 300 1 750 1 750 1 1500 1 1500 1 20000 1
56 0 0 0 0 0 0 0 0 0 0 0 0
63 0 0 0 0 0 0 0 0 0 0 0 0
70 0 0 0 0 0 0 0 0 0 0 0 0
77 0 0 0 0 0 0 0 0 0 0 0 0
85 0 0 0 0 0 0 0 0 0 0 0 0
88 0 0 0 0 0 0 0 0 0 0 0 0
95 0 0 0 0 0 0 0 0 0 0 0 0
99 0 0 0 0 0 0 0 0 0 0 0 0
109 0 0 0 0 0 0 0 0 0 0 0 0
116 0 0 0 0 0 0 0 0 0 0 0 0
151 0 0 0 0 0 0 0 0 0 0 0 0
Legend: for HCT: estimated numbers of trypanosomes/ml; for PCR: 0 negative; 1 positive.
1137Cymelarsan eﬃcacy on surra in cattle
http://dx.doi.org/10.1017/S0031182011000771
Downloaded from http:/www.cambridge.org/core. Open University Libraryy, on 22 Dec 2016 at 23:11:35, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms.
before the end of the experiment on Day 119. It was
necropsied and additional examinations were carried
out. BMIT, CSFMIT, and microscopic examination
of the buﬀy coat, stained brain smears, as well as PCR
and microscopic examination of pellets from CSF,
joint ﬂuid and aqueous humour of the eyes, were all
negative for trypanosomes. The RPP in ELISA was
below the positive threshold from Day 95 (45 days
p.t.) to Day 119 when the animal died. Apart from a
single positive result on Day 29, CATT/T. evansi
remained negative in this animal.
By the end of the experiment, all animals had given
negative results in all the parasitological, molecular
and serological tests (apart from ELISA in heifer
C32, which will be discussed in the next section) for a
period of at least 3 weeks, including 1 negative BMIT
and 1 negative CSFMIT.
DISCUSSION
In vitro protocols and in vivo rodent protocols have
been developed to evaluate chemo‑resistance to
-20%
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Days post-infection 
RPP (ELISA) C22 C21 C32
Fig. 1. Monitoring of ELISA results in 3 normal cattle experimentally infected with Trypanosoma evansi and treated
with melarsomine hydrochloride. RPP, relative percentage of positivity (%) in ELISA; Day 0, date of infection; Day 50,
date of treatment; Day 19, date of cerebrospinal ﬂuid mouse inoculation test (CSFMIT) and blood mouse inoculation
test (BMIT).
Table 2. Results of the CATT/T. evansi in 3 normal and 3 splenectomized cattle experimentally infected by
Trypanosoma evansi (D0) and treated with melarsomine hydrochloride (D50)
Animal numbers
C22 C21 C32 SC17 SC16 SC9Day post-infection
0 0 0 0 0 0 0
6 0 0 0 0 +/− 0
21 0 0 0 0 0 0
27 0 0 0 0 0 +++
29 0 0 +/− ++ 0 ++
35 0 0 +/− 0 0 ++
42 0 0 +/− 0 0 +
50 0 0 +/− 0 0 +/−
56 0 0 +/− 0 0 0
63 0 0 0 0 0 0
70 0 0 0 0 0 0
77 0 0 0 0 0 0
85 0 0 0 0 0 0
88 0 0 0 0 0 0
95 0 0 0 0 0 0
99 0 0 0 0 0 0
109 0 0 0 0 0 0
116 0 0 0 0 0 0
151 0 0 0 0 0 0
Legend: 0, negative; +/−, doubtful; +, positive; ++, strong positive; +++, very strong positive.
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trypanocides (Eisler et al. 2001). However, the only
way to assess the eﬃcacy of a trypanocide in a given
host is to carry out the experiment in that very host.
For this reason, despite its high cost and substantial
inconvenience, our experiment could only be carried
out on dairy cattle. Based on previous observations
(Dia and Desquesnes, 2007), it is already known that
a dose of 0·25 mg/kg is not eﬀective in cattle, so there
was no need for an untreated control group in our
study.
The evaluation of a trypanocide is intended to
determine the precise eﬀect of the treatment. Does it
kill all parasites, leading to a fully curative treatment,
or does it only kill most of the parasites, leaving some
of them alive, which leads to healthy carriers and a
possible infection relapse under particular conditions
such as physical stress (restraining for vaccination),
food reduction or drought? This was demonstrated
under experimental conditions with Latin American
T. evansi in sheep (Desquesnes, 2004). In the case
of T. evansi, which tends to penetrate deep into the
tissues and cross most biological barriers, it has even
been reported that parasites can survive in extra-
vascular foci such as cerebrospinal ﬂuid or joint ﬂuid
(Schillinger and Röttcher, 1986). In T. vivax, the
aqueous humour of the eyes was also described as a
potential extravascular focus (Whitelaw et al. 1988).
Consequently, some of these foci were included in
our study to ensure total elimination of the parasites.
Parasitaemia may sometimes remain undetectable
in partially immune animals, especially in the case
of T. evansi in cattle, since they naturally develop
very low parasitaemia. It is therefore impossible to
demonstrate the eﬃcacy of a treatment based on
parasitological examination alone. To determine if
any animal is still harbouring parasites after treat-
ment, protocols must include serological follow-up.
If the infection persists, immune stimulation would
also persist and the RPP values in ELISA should stay
above the positive threshold.
In our study, in the group of 3 normal cattle, if the
treatment had failed to eliminate the parasites,
immune stimulation would have been detected
through persisting high RPP values in ELISA. In
our observations, the RPP regularly decreased, fall-
ing below the positive threshold 45 (±25) days after
treatment. In 1 animal, which proved to give high
serological responses (C32), the RPP was still
ﬂuctuating around the positive threshold when the
experiment ended. However, these regularly decreas-
ing ELISA results, combined with the negative
results obtained in all the other tests, including
observation under the microscope, PCR, CATT,
BMIT and CSFMIT, strongly support the hypoth-
esis of a fully curative treatment, without refuge. It
might be advisable to extend the follow-up of such
animals when BMIT and CSFMIT cannot be
carried out, but in our study all the results gathered
allowed us to conclude on the absence of remaining
infection. However, in our case, CSF was not
examined before treatment, so it was not possible to
assess whether the treatment might cure CSF
infection or not.
The CATT performed very poorly since only 2
animals gave scarce positive results; the mean of
positive results obtained from the samples collected
during the period of active infection (from Day 6 to
Day 50) was as low as 12% (5/42). When doubtful
results were included, it reached 26%. A new batch of
CATT T. evansi gave similar results. The results in
the normal cattle (4 out of 28 samples from infected
animals were doubtful) were worse than in the
splenectomized cattle (5 positive and 2 doubtful out
of 28 samples from infected animals). With 86%
-20%
0%
20%
40%
60%
80%
100%
120%
0 15 29 50 60 70 81 91 102 112 123 134 144
Days post-infection
RPP (ELISA) SC17 SC16 SC9
Fig. 2. Monitoring of ELISA results in 3 splenectomized cattle experimentally infected with Trypanosoma evansi and
treated with melarsomine hydrochloride. RPP, relative percentage of positivity (%) in ELISA; Day 0, date of infection;
Day 50, date of treatment; Day 99 date of cerebrospinal ﬂuid mouse inoculation test (CSFMIT) and blood mouse
inoculation test (BMIT).
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false-negative results, the sensitivity of the CATT
was too low to be useful in our study. Other authors
had already recorded this lack of sensitivity in pigs
(Holland et al. 2005) but not yet in bovines; the
usefulness of the CATT in cattle is therefore still
uncertain, especially its negative predictive value,
which was very low in our experiment.
In the group of 3 splenectomized cattle, if the
treatment had failed to completely eliminate the
parasites, the serological response might not have
been detected due to the immunosuppressive eﬀects
of the splenectomy, but the parasitaemia ought to
have increased (due to the immunodeﬁciency) and
have been easily detected. This was not the case, since
all the parasitological (and serological) examinations
remained negative. Similarly, no cerebrospinal ﬂuid
refuge could be detected. Moreover, in the animal
that died of anaplasmosis, the extensive search for the
parasite in cerebrospinal, joints and eye ﬂuids was
negative. The fact that no relapse could be observed
in the splenectomized animals gives satisfactory cause
for conﬁdence that the treatment is suitable for
application in the ﬁeld, where animals are sometimes
immunosuppressed by intercurrent diseases.
Based on all these results, we concluded that
treatment of the 6 dairy cattle was fully curative and
the parasites were completely eliminated. These
observations are quite closely related to previously
published results in cattle or buﬀaloes (Lun et al.
1991; Zweygarth et al. 1992; Payne et al. 1994b). In
particular, a recent observation in African cattle
experimentally infected with the African strain of T.
evansi from the North of Burkina Faso demonstrated
that the dose of 0·5 mg/kg was eﬀective in curing the
animals, while preliminary tests using 0·25mg/kg
showed relapses (Dia and Desquesnes, 2007).
The policy for trypanocidal drug use in Thailand
calls for discussion. Although the manufacturer’s
leaﬂet recommends using diminazene aceturate (DA)
at a dose of 7 mg/kg to control Trypanozoon in-
fections, for unknown reasons and out of habit,
veterinarians in Thailand are used to applying
3·5 mg/kg only. Moreover, under the pressure of
farmers who believe that this treatment may induce
shock and a febrile side eﬀect, the booster dose is
sometimes divided into 2×1·75mg/kg subdoses
injected 24 h apart. In such circumstances, DA has
been extensively under-dosed in Thailand for years.
The 3·5 mg/kg dose most probably does not kill all
the parasites and then helps to boost the immune
responses of the animals, leading to unhealthy and
healthy enzootic parasite carriers. This situation was
conﬁrmed by the high prevalence observed on
infected farms, in a recent dairy cattle survey
(Desquesnes et al. 2009). This under-dosing has
applied for years in horses, mules, buﬀaloes and cattle
and is most probably responsible for drug resistance
in the ﬁeld. In equines, for example, up to 50% of
relapses were observed early after 3·5 mg/kg DA
treatments (Tuntasuvan et al. 2003a). Similarly in
buﬀaloes, treatment at 5 mg/kg DA was also un-
successful (Pholpark et al. 1984). As the under-
dosing of DA in Thailand has long been the rule,
both in equines and bovines, veterinarians had to
increase the dose to 7mg/kg, after some strains were
selected for their resistance to 3·5 mg/kg, in order to
overcome the rapid relapse of clinical signs, which
after a time was also no longer eﬀective. Field
observations have indicated that in some cases
10mg/kg of DA is no longer eﬀective, and relapses
occur very rapidly after treatment (P. Rodtian,
unpublished data). In such circumstances, it is
strongly recommended that DA use be halted and
that such strains be eliminated with a trypanocide of
another chemical family. In this context, Thailand
urgently needs to identify such eﬀective trypano-
cides. From our results, melarsomine hydrochloride
could be proposed as a drug of choice to replace DA,
especially in cases of apparent resistance to DA
observed in the ﬁeld.
We concluded from our experiment that the treat-
ment of normal and splenectomized cattle was fully
curative and the parasites were completely elimi-
nated. The evidence provided by the eﬃcacy in
splenectomized cattle demonstrated that the chemi-
cal itself was responsible for the curative action, even
with a depressed immune system. This showed
potential satisfying treatment security, even under
ﬁeld conditions where some animals might be im-
munosuppressed by concurrent diseases or by un-
favourable zootechnical parameters (food or water
supply, endo- or ectoparasitic infestation, etc.).
Melarsomine hydrochloride at the dose of 0·5 mg/kg
can be recommended for treatment of surra in dairy
cattle in Thailand. Such a dosage has already been
suggested in China to treat buﬀaloes (Lun et al.
1991). However, larger-scale studies would be
welcome to provide further information on the
eﬃcacy of this treatment in bovines.
With the increasing impact of surra in Asia
(Dargantes et al. 2009; Dobson et al. 2009), including
India (Laha and Sasmal, 2009), especially due to
spontaneous abortion (Löhr et al. 1986; Kashiwazaki
et al. 1998), a reduction in milk production
(Sarataphan et al. 1989; Pholpark et al. 1999), and
interference in the Foot and Mouth and Haemor-
rhagic Septicaemia vaccination programme (Onah
et al. 1997; Holland et al. 2001; Singla et al. 2010),
this would be a good time to identify and make
available eﬀective tools for the chemical control
of surra.
Although this work demonstrated the potential
merits of melarsomine hydrochloride for treating
cattle infected by T. evansi, it did not demonstrate
the passage of melarsomine hydrochloride through
the haematoencephalic barrier. Further work will be
necessary to demonstrate the eﬃcacy of the treatment
in cattle proved to be CSF infected, before such
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treatment can be proposed as an alternative to culling
cattle, should T. evansi be accidentally introduced
into Europe, as recently seen in continental Spain and
France (Gutierrez et al. 2010).
ACKNOWLEDGEMENTS
We wish to express our sincere gratitude to the Thailand
International Cooperation Agency (TICA) for the ﬁnancial
and diplomatic support contributed to the project. Thanks
to Merial for providing Cymelarsan and partial support
of the maintenance expenses for the cattle. This research
was also funded by Kasetsart University Research and
Development Institution (Kor-Sor-Dor. 65.51), Kasetsart
University and CIRAD which kindly supported the
maintenance expenses for the cattle.
CONFLICT OF INTEREST STATEMENT
All the authors declare that they have no ﬁnancial and
personal relationships with other people or organizations
that could inappropriately inﬂuence (bias) their work,
including employment, consultancies, stock ownership,
honoraria, paid expert testimony, patent application/
registration, and grant or other funding.
REFERENCES
Ancelle, T. (2002). Statistique, Épidemiologie. Collection “Sciences
Fondamentales” (directed by d’Ivernois, J.-F.), Editions Maloine, Paris,
France.
Bajyana Songa, E. and Hamers, R. (1988). A card agglutination test
(CATT) for veterinary use based on an early VAT RoTat 1/2 of
Trypanosoma evansi. Annales de la Société Belge de Médecine Tropical 68,
233–240.
Chobjit, S., Kheowsri, S., Rodtian, P., Jongchansittoe, P. and
Nuangmek, A. (2006). An outbreak of bovine surra in Maehongsorn
Province. Chiang Mai Veterinary Journal 4, 127–136.
Dargantes, A. P., Mercado, R. T., Dobson, R. J. and Reid, S. A. (2009).
Estimating the impact of Trypanosoma evansi infection (surra) on buﬀalo
population dynamics in southern Philippines using data from cross-
sectional surveys. International Journal for Parasitology 39, 1109–1114.
Desquesnes, M. (2004). Livestock trypanosomoses and their vectors in Latin
America, CIRAD-EMVT publication, OIE, Paris, ISBN 92-9044-634-X;
174. http://www.oie.int/doc/ged/D9818.PDF.
Desquesnes,M., Bosseno,M. F. and Breniere, S. F. (2007). Detection of
Chagas infections using Trypanosoma evansi crude antigen demonstrates
high cross-reactions withTrypanosoma cruzi. Infection Genetic and Evolution
7, 457–462.
Desquesnes, M., Kamyingkird, K., Pruvot, M., Kengradomkij, C.,
Bossard, G., Sarataphan, N. and Jittapalapong, S. (2009). Antibody-
ELISA for Trypanosoma evansi: Application in a serological survey of dairy
cattle, Thailand, and validation of a locally produced antigen. Preventive
Veterinary Medicine 90, 233–241.
Desquesnes, M. and Tresse, L. (1996). Evaluation de la sensibilité du test
de WOO pour la détection de Trypanosoma vivax. Revue d’élevage et de
Médecine Vétérinaire des Pays Tropicaux 49, 315–321.
Dia, M. and Desquesnes, M. (2007). Infections expérimentales de bovins
par Trypanosoma evansi: pathogénicité et eﬃcacité du traitement au
Cymelarsan®.Revue Africaine de Santé et de Productions Animales. 5, 37–41.
Dobson, R. J., Dargantes, A. P., Mercado, R. T. and Reid, S. A. (2009).
Models for Trypanosoma evansi (surra), its control and economic impact on
small-hold livestock owners in the Philippines. International Journal for
Parasitology 39, 1115–1123.
Eisler, M. C., Brandt, J., Bauer, B., Clausen, P. H., Delespaux, V.,
Holmes, P. H., Ilemobade, A., Machila, N., Mbwambo, H.,
McDermott, J., Mehlitz, D., Murilla, G., Ndung’u, J.M.,
Peregrine, A. S., Sidibe, I., Sinyangwe, L. and Geerts, S. (2001).
Standardised tests in mice and cattle for the detection of drug resistance in
tsetse-transmitted trypanosomes of African domestic cattle. Veterinary
Parasitology 97, 171–182.
Gill, B. S. (1977). Trypanosomes and Trypanosomiases of Indian Livestock.
Indian Council of Agricultural Research (ICAR), New Delhi, India.
Gutierrez, C., Desquesnes, M., Touratier, L. and Buscher, P. (2010).
Trypanosoma evansi: recent outbreaks in Europe. Veterinary Parasitology
174, 26–29.
Hin-On, W., Rodtian, P., Nuangmek, A., Uthaiwan, V. and
Muangyai, M. (2004). Surra in timber elephant from Northern
Thailand; diagnosis and treatment; a case study. In: Proceedings of the
30th Annual Conference of the Thai Veterinary Medical Association,
Bangkok, Thailand, 10–12 November 2004, pp. 373–385.
Holland, W.G., My, L. N., Dung, T. V., Thanh, N. G., Tam, P. T.,
Vercruysse, J. and Goddeeris, B.M. (2001). The inﬂuence of
Trypanosoma evansi infection on the immuno-responsiveness of experimen-
tally infected water buﬀaloes. Veterinary Parasitology 102, 225–234.
Holland, W.G., Thanh, N. G., Do, T. T., Sangmaneedet, S.,
Goddeeris, B. and Vercruysse, J. (2005). Evaluation of diagnostic tests
for Trypanosoma evansi in experimentally infected pigs and subsequent use
in ﬁeld surveys inNorthVietnam andThailand.Tropical AnimalHealth and
Production 37, 457–467.
Indrakamhang, P. (1998). Trypanosoma evansi infection in livestock in
Thaïland. Journal of Protozoological Research 8, 153–161.
Kashiwazaki, Y., Pholpark, M., Polsar, C. and Pholpark, S. (1998).
Haemoparasite infections in newly introduced dairy cattle in Loei Province,
Thailand: Trypanosoma evansi antigen levels by ELISA referring to
abortion. Veterinary Parasitology 80, 99–109.
Laha, R. and Sasmal, N. K. (2009). Detection of Trypanosoma evansi
infection in clinically ill cattle, buﬀaloes and horses using various diagnostic
tests. Epidemiology and Infection 1–3.
Löhr, K. F., Pholpark, S., Siriwan, P., Leesirikul, N., Srikitjakarn, L.
and Staak, C. (1986). Trypanosoma evansi infection in buﬀaloes in North-
East Thailand. II. Abortions. Tropical Animal Health and Production 18,
103–108.
Luckins, A. G. (1988). Trypanosoma evansi in Asia. Parasitology Today 4,
137–142.
Lun, Z.-R., Min, Z.-P., Huang, D., Liang, J.-X., Yang, X.-F. and
Huang, Y.-T. (1991). Cymelarsan in the treatment of buﬀaloes naturally
infected with Trypanosoma evansi in South China. Acta Tropica 49,
233–236.
Masiga, D. K., Smyth, A. J., Hayes, P., Bromidge, T. J. and
Gibson, W. C. (1992). Sensitive detection of trypanosomes in tsetse ﬂies
by DNA ampliﬁcation. International Journal for Parasitology 22, 909–918.
Onah, D.N., Hopkins, J. and Luckins, A. G. (1997). Eﬀects of
Trypanosoma evansi on the output of cells from a lymph node draining the
site of Pasteurella haemolytica vaccine administration. Journal of
Comparative Pathology 117, 73–82.
Panyim, S., Viseshakul, N., Luxananil, P., Wuyts, N. and
Chokesajjawatee, N. (1993). A PCRmethod for highly sensitive detection
of Trypanosoma evansi in blood samples. Proceedings of EEC Contractants
Workshops. Resistance or Tolerance of Animals to Diseases and Veterinary
Epidemiology and DiagnosticMethods, Rethymno, Greec, 2–6November 1992;
edited by CIRAD-EMVT, pp. 138–143.
Payne, R. C., Sukanto, I. P., Partoutomo, S. and Jones, T.W. (1994a).
Eﬃcacy of Cymelarsan treatment of suramin resistant Trypanosoma evansi
in cattle. Tropical Animal Health and Production 26, 92–94.
Payne, R. C., Sukanto, I. P., Partoutomo, S., Jones, T.W.,
Luckins, A. G. and Boid, R. (1994b). Eﬃcacy of Cymelarsan in Friesian
Holstein calves infected with Trypanosoma evansi. Tropical Animal Health
and Production 26, 219–226.
Pholpark, S., Pholpark, M., Polsar, C., Charoenchai, A.,
Paengpassa, Y. and Kashiwazaki, Y. (1999). Inﬂuence of Trypanosoma
evansi infection on milk yield of dairy cattle in northeast Thailand.
Preventive Veterinary Medicine 42, 39–44.
Pholpark, S., Pholpark, M., Sarataphan, N., Khunpasi, S. and
Taboran, P. (1984). Trypanosoma evansi infection in buﬀalo in Northeast
Thailand. 2 Experimental study. In Proceedings of the 11th Annual
Conference of the Thailand Veterinary Medical Association, Bangkok,
Thailand, 4–6 November 1984, pp. 44–45.
Reid, S. A. (2002). Trypanosoma evansi control and containment in
Australasia. Trends in Parasitology 18, 219–224.
Sambrook, J. and Russell, D. (2001). Molecular Cloning: A Laboratory
Manual (3rd Edn.) Cold Spring Harbor Laboratory Press. Cold Spring
Harbor, New York, USA.
Sarataphan, N., Nishikawa, H., Tuntasuvan, D., Sukhapesna, V.,
Markvishitr, K. and Satjapitak, S. (1989). Eﬀects of naturalTrypanosoma
evansi infection on milk yield of dairy cattle in Thailand. Proceedings of the
First Symposium on Ruminant Reproduction and Parasitology, Chiang Maï,
Thailand, 27–29 November, pp. 331–343.
Schillinger, D. and Röttcher, D. (1986). Traitement de l’infection
cameline due à Trypanosoma evansi (surra). Revue mondiale de Zootechnie
26–32.
1141Cymelarsan eﬃcacy on surra in cattle
http://dx.doi.org/10.1017/S0031182011000771
Downloaded from http:/www.cambridge.org/core. Open University Libraryy, on 22 Dec 2016 at 23:11:35, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms.
Singla, L. D., Juyal, P. D. and Sharma, N. S. (2010). Immune
responses to haemorrhagic septicaemia (HS) vaccination in
Trypanosoma evansi infected buﬀalo-calves. Tropical Animal Health and
Production 42, 589–595.
Tuntasuvan, D. and Luckins, A. (1998). Status of Surra in livestock in
Thailand. Journal of Protozoological Research 8, 162–170.
Tuntasuvan, D., Jarabrum, W., Viseshakul, N., Mohkaew, K.,
Borisutsuvan, S., Theeraphan, A. and Kongkanjana, N. (2003a).
Chemotherapy of surra in horses and mules with diminazene aceturate.
Veterinary Parasitology 110, 227–233.
Tuntasuvan, D., Trongwanichnam,K., Sukruen, A., Borisutsuvan, S.,
Mohkaew, K. and Chompoochan, T. (2003b). Eﬃcacy of Diminazene
Aceturate on the treatment of trypanosomosis in pigs. Journal of the Thai
Veterinary Medicine Association 54, 49–55.
Whitelaw, D. D., Gardiner, P. R. andMurray, M. (1988). Extravascular
foci of Trypanosoma vivax in goats: the central nervous system and aqueous
humour of the eye as potential sources of relapse infections after
chemotherapy. Parasitology 97, 51–61.
Woo, P. T. K. (1970). The haematocrit centrifuge technique for diagnosis of
African trypanosomiasis. Acta Tropica 27, 384–386.
Zweygarth, E., Ngeranwa, J. and Kaminsky, R. (1992). Preliminary
observations on the eﬃcacy of mel Cy (Cymelarsan) in domestic animals
infected with stocks of Trypanosoma brucei brucei and T. b. evansi. Tropical
Medicine and Parasitology 43, 226–228.
1142Marc Desquesnes and others
http://dx.doi.org/10.1017/S0031182011000771
Downloaded from http:/www.cambridge.org/core. Open University Libraryy, on 22 Dec 2016 at 23:11:35, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms.
